Aarti Drugs (BOM:524348) COGS-to-Revenue : 0.64 (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs COGS-to-Revenue?

Aarti Drugs's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹3,971 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹6,200 Mil.

Aarti Drugs's COGS to Revenue for the three months ended in Mar. 2024 was 0.64.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Aarti Drugs's Gross Margin % for the three months ended in Mar. 2024 was 35.95%.

Aarti Drugs COGS-to-Revenue Historical Data

The historical data trend for Aarti Drugs's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs COGS-to-Revenue Chart

Aarti Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.78

0.72

0.80

0.70

0.66

Aarti Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.69	0.68	0.67	0.67	0.64

Aarti Drugs COGS-to-Revenue Calculation

Aarti Drugs's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	16777.2	/	25285.8
	=	0.66

Aarti Drugs's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3971.1	/	6199.9
	=	0.64

Aarti Drugs (BOM:524348) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Aarti Drugs's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3971.1 / 6199.9
	=	35.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Aarti Drugs COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Drugs (BOM:524348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

AARTIDRUGS:India

Address

Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022

Website

https://www.aartidrugs.co.in

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines